COULD THIS BE THE MOMENT THAT DRUG MANUFACTURING TAKES OFF IN ORBIT?

Summary from the TLDR newsletter

Vada Space Industries, a private space company, has announced a significant new collaboration with the United Therapeutics Corporation to explore the use of microgravity to develop improved treatments for rare lung disease. The companies plan to use microgravity's influence on the structure and crystallization properties of therapeutic compounds to improve their stability and delivery. This is the first time a large, publicly traded company is using capital from its own balance sheet to build and produce a product in microgravity. Up to now, NASA has subsidized much of the research into the impact of microgravity on drug development.